About

MTS COMPANY

Since 2020, MTS COMPANY has been at the forefront of developing cutting-edge AI-powered solutions for medical diagnosis and prediction, with a dedicated focus on oncology.

Driven by a commitment to conquering cancer, we specialize in developing sophisticated AI platforms that empower healthcare professionals in pathology and radiology.

By harnessing the power of artificial intelligence, we strive to enhance diagnostic accuracy, optimize treatment strategies, and ultimately improve patient outcomes and quality of life.

Meet Our Team

We are dedicated to developing better diagnostic and predictive solutions, striving to win the fight against cancer.

Our Partners

AiAlpa-Platform is the result of a powerful collaboration, developed and rigorously validated in conjunction with 12 leading university hospitals and over 100 board-certified pathologists, ensuring its clinical robustness and real-world applicability.

MTS Company is a leading company in the digital health sector, specializing in AI-based technology, offering highly effective AI-assisted cancer diagnosis and prediction solutions.